Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Personalised information for improving the uptake of smoking cessation programs.

Semwal M, Taylor G, Car J.

Ann Transl Med. 2017 Jun;5(12):260. doi: 10.21037/atm.2017.04.02. No abstract available.

2.

Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial.

Gilbert H, Sutton S, Morris R, Petersen I, Galton S, Wu Q, Parrott S, Nazareth I.

Lancet. 2017 Feb 25;389(10071):823-833. doi: 10.1016/S0140-6736(16)32379-0. Epub 2017 Jan 25.

3.

A Systematic Review of the Effect of Individualized Risk Communication Strategies on Screening Uptake and Its Psychological Predictors: The Role of Psychology Theory.

Bould K, Daly B, Dunne S, Scott S, Asimakopoulou K.

Health Psychol Res. 2016 Dec 9;4(2):6157. doi: 10.4081/hpr.2016.6157. eCollection 2016 Dec 9.

4.

Can a print-based intervention increase screening for first degree relatives of people with colorectal cancer? A randomised controlled trial.

Carey M, Sanson-Fisher R, Macrae F, Cameron E, Hill D, D'Este C, Simmons J, Doran C.

Aust N Z J Public Health. 2016 Dec;40(6):582-587. doi: 10.1111/1753-6405.12579. Epub 2016 Sep 13.

5.

Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling?

Chowdhury S, Henneman L, Dent T, Hall A, Burton A, Pharoah P, Pashayan N, Burton H.

J Pers Med. 2015 Jun 9;5(2):191-212. doi: 10.3390/jpm5020191. Review.

6.

The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting.

Willis A, Rivers P, Gray LJ, Davies M, Khunti K.

PLoS One. 2014 Apr 1;9(4):e91157. doi: 10.1371/journal.pone.0091157. eCollection 2014.

7.

Methods to increase participation in organised screening programs: a systematic review.

Camilloni L, Ferroni E, Cendales BJ, Pezzarossi A, Furnari G, Borgia P, Guasticchi G, Giorgi Rossi P; Methods to increase participation Working Group.

BMC Public Health. 2013 May 13;13:464. doi: 10.1186/1471-2458-13-464. Review.

8.

Predictors of risk-based medical follow-up: a report from the Childhood Cancer Survivor Study.

Steele JR, Wall M, Salkowski N, Mitby P, Kawashima T, Yeazel MW, Hudson MM, Robison LL, Mertens AC.

J Cancer Surviv. 2013 Sep;7(3):379-91. doi: 10.1007/s11764-013-0280-z. Epub 2013 Apr 9.

9.

Incorporating genomics into breast and prostate cancer screening: assessing the implications.

Chowdhury S, Dent T, Pashayan N, Hall A, Lyratzopoulos G, Hallowell N, Hall P, Pharoah P, Burton H.

Genet Med. 2013 Jun;15(6):423-32. doi: 10.1038/gim.2012.167. Epub 2013 Feb 14. Review.

10.

Computer-delivered tailored intervention improves colon cancer screening knowledge and health beliefs of African-Americans.

Rawl SM, Skinner CS, Perkins SM, Springston J, Wang HL, Russell KM, Tong Y, Gebregziabher N, Krier C, Smith-Howell E, Brady-Watts T, Myers LJ, Ballard D, Rhyant B, Willis DR, Imperiale TF, Champion VL.

Health Educ Res. 2012 Oct;27(5):868-85. Epub 2012 Aug 27.

11.

Primary prevention of cardiovascular disease using validated risk scores: a systematic review.

Willis A, Davies M, Yates T, Khunti K.

J R Soc Med. 2012 Aug;105(8):348-56. doi: 10.1258/jrsm.2012.110193. Erratum in: J R Soc Med. 2012 Oct;105(10):411.

12.

Decision boxes for clinicians to support evidence-based practice and shared decision making: the user experience.

Giguere A, Légaré F, Grad R, Pluye P, Haynes RB, Cauchon M, Rousseau F, Alvarez Argote J, Labrecque M.

Implement Sci. 2012 Aug 3;7:72. doi: 10.1186/1748-5908-7-72.

13.

Patient follow-up after participating in a beach-based skin cancer screening program.

Greaney ML, Puleo E, Geller AC, Hu SW, Werchniak AE, DeCristofaro S, Emmons KM.

Int J Environ Res Public Health. 2012 May;9(5):1836-45. doi: 10.3390/ijerph9051836. Epub 2012 May 10.

14.

Knowledge translation of research findings.

Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE.

Implement Sci. 2012 May 31;7:50. doi: 10.1186/1748-5908-7-50.

15.

Preferences for CT colonography and colonoscopy as diagnostic tests for colorectal cancer: a discrete choice experiment.

Howard K, Salkeld G, Pignone M, Hewett P, Cheung P, Olsen J, Clapton W, Roberts-Thomson IC.

Value Health. 2011 Dec;14(8):1146-52. doi: 10.1016/j.jval.2011.07.012.

16.

Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial.

Rubinstein WS, Acheson LS, O'Neill SM, Ruffin MT 4th, Wang C, Beaumont JL, Rothrock N; Family Healthware Impact Trial (FHITr) Group.

Genet Med. 2011 Nov;13(11):956-65. doi: 10.1097/GIM.0b013e3182241d88.

17.

Dealing with substantial heterogeneity in Cochrane reviews. Cross-sectional study.

Schroll JB, Moustgaard R, Gøtzsche PC.

BMC Med Res Methodol. 2011 Feb 24;11:22. doi: 10.1186/1471-2288-11-22.

18.

Genetic risk, perceived risk, and cancer worry in daughters of breast cancer patients.

Quillin JM, Bodurtha JN, McClish D, Wilson DB.

J Genet Couns. 2011 Apr;20(2):157-64. doi: 10.1007/s10897-010-9336-7. Epub 2010 Dec 4.

19.

Personal attributions for melanoma risk in melanoma-affected patients and family members.

Hay J, DiBonaventura M, Baser R, Press N, Shoveller J, Bowen D.

J Behav Med. 2011 Feb;34(1):53-63. doi: 10.1007/s10865-010-9286-4. Epub 2010 Sep 1.

20.

Supplemental Content

Support Center